Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec

Wed, 16th Sep 2020 16:08

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and Wednesday and not separately reported by Alliance News:

----------

Cora Gold Ltd - West Africa gold explorer - Hires Norm Bailie as head of exploration, effective immediately, replacing retiring Cora Co-Founder Jon Forster. Bailie was group exploration manager for FTSE 250 Egyptian gold miner Centamin PLC. Non-Executive Chair Ed Bowie says of Bailie: "The addition of an individual with his experience and expertise has come at an exciting time for Cora, specifically as we move forward to our next field season and continue working towards the completion of a definitive feasibility study on Sanankoro by the end of 2021. Having been involved in over 30Moz of discovery and definition in Africa during his career he is ideally suited to help take Cora to the next stage."

----------

First Derivatives PLC - Newry, Northern Ireland-based financial software and services - Hires Steve Fisher as non-executive director from Tuesday. Fisher was chief technology officer of US-based online marketplace eBay Inc, prior to which he was with customer relationship management software provider salesforce.com Inc.

----------

Equals Group PLC - London-based payment and currency services - Appoints Sian Herbert as an independent non-executive director, effective October 1. Herbert was with PricewaterhouseCoopers LLP for 25 years, 15 as a partner, before stepping down in June. Bob Head steps down at the same time, after four years on the board.

----------

Blue Prism Group PLC - Warrington, England-based robotic process automation - Charmaine Carmichael steps down as non-executive director from September 30, after more than four years, as a result of taking up a new full-time executive position. Blue Prism has started search for new non-executive director.

----------

Tasty PLC - London-based operator of casual dining restaurants - Adam Kaye resigns as non-executive director, effective Tuesday, to focus on other commercial interests. Tasty notes that Kaye has been part of the business since the start and has been instrumental in shaping its strategy. Tasty will look for an additional independent non-executive director.

----------

Clinigen Group PLC - Burton On Trent, Staffordshire-based pharmaceuticals and services - John Hartup to step down as senior independent non-executive director at November 26 annual general meeting. Says board nomination committee to appoint new independent non-executive director and pick new senior independent director from among non-executive directors.

----------

FirstGroup PLC - Aberdeen-headquartered public transport - Ant Green joins board as employee director from Tuesday. Green is a bus driver and trainer for First Bus.

----------

KKV Secured Loan Fund Ltd - Hires Brett Miller as director, effective immediately. Miller is a director of Secured Income Fund PLC, which like KKV Secured is managed by KKV Investment Management Ltd, so won't be consider independent. Miller will work for six months as well with the manager in part to effect an orderly realisation of assets to C shareholders.

----------

Baker Steel Resources Trust Ltd - invests in equities, loans or related instruments of natural resources companies - Fiona Perrott-Humphrey appointed as an independent non-executive director from Tuesday, replacing Clive Newall, who has resigned. Perrott-Humphrey was head of Mining Research for Europe & South Africa at Citigroup Inc.

----------

BioPharma Credit PLC - life sciences debt investment trust - Appoints Rolf Soderstrom as non-executive director from Wednesday. Soderstrom was chief financial officer of BTG PLC until 2018 and prior to that in senior finance roles at Cobham PLC and Cable & Wireless PLC. He is senior independent director of London-listed Ergomed PLC.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2019 10:43

WINNERS & LOSERS SUMMARY: Tullow Oil Up 6% After Reinstating Dividend

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------Smurfit

Read more
13 Feb 2019 10:05

Clinigen bounds upwards on purchase of Proleukin's US rights

(Sharecast News) - Clinigen Group shares jumped on Wednesday after the company signed an agreement with Novartis to acquire the US rights to its Proleukin drug for up to $210m in cash.

Read more
13 Feb 2019 08:42

Clinigen Stock Climbs As It Buys Proleukin's US Rights From Novartis

LONDON (Alliance News) - Pharmaceuticals firm Clinigen Group PLC's shares rose early Wednesday as it announced the purchase of the rights to one of Novartis International AG's were up 12%

Read more
5 Feb 2019 10:49

Clinigen Group Appoints Accountant Nick Keher Chief Financial Officer

LONDON (Alliance News) - Clinigen Group PLC on Tuesday said it appointed Nick Keher as group chief financial officer with effect from March 19.Keher replaces current CFO Martin Abell, who a

Read more
5 Feb 2019 07:56

Clinigen appoints Nick Keher as new CFO

(Sharecast News) - AIM-listed pharmaceutical and services company Clinigen Group has appointed Nick Keher as its new chief financial officer with effect from 19 March.

Read more
15 Jan 2019 09:37

Clinigen Outlook Confident As Revenue And Profit Grow In First Half

LONDON (Alliance News) - Clinigen Group PLC on Tuesday expressed confidence in delivering progress in its full financial year after it saw a strong earnings growth in the first half.The for

Read more
15 Jan 2019 09:22

Acquisitions spur Clinigen to profit and revenue growth

(Sharecast News) - Clinigen Group on Tuesday reported that, following a series of acquisitions, it expects to report a sharp rise in revenue and profit when it publishes its half-year results next month.

Read more
1 Nov 2018 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Friday 2 NovemberMurgitroyd GroupMonday 5 NovemberRandgold Resources (re Barrick Gold

Read more
27 Sep 2018 17:45

UPDATE: Clinigen In Placing For Two New Purchases; Earnings Jump (ALLISS)

LONDON (Alliance News) - Clinigen Group PLC on Thursday said it placed 9.5 million shares at a price of 845 pence each, raising GBP80 million.The stock closed 11% lower on Thursday at per a

Read more
27 Sep 2018 12:14

Thursday broker round-up

(Sharecast News) - Thomas Cook Group: UBS upgrades to neutral with a target price of 60p.

Read more
27 Sep 2018 10:05

Clinigen In Share Placing For Two New Purchases; Annual Earnings Jump (ALLISS)

LONDON (Alliance News) - Clinigen Group PLC on Thursday announced a share placing to help pay for the acquisition of packaging and distribution services company CSM Parent Inc for up to USD240 in

Read more
27 Sep 2018 08:04

Clinigen announces two new acquisition targets following 'another year of good progress'

(Sharecast News) - Clinigen plans to raise £80m from investors to fund two new acquisitions following a "strong performance" from one of its previous additions in its last trading year.

Read more
20 Sep 2018 16:12

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 21 September Smiths GroupFull Year ResultsSIGHalf Year SaatchiHalf Year +

Read more
25 Jul 2018 14:40

Clinigen makes second July drug acquisition

(Sharecast News) - Pharmaceutical and services company Clinigen has acquired the global rights to severe malignant osteoperosis treatment Imukin from Horizon Pharma for an undisclosed sum.

Read more
25 Jul 2018 09:48

Clinigen Acquires Global Rights For Osteoporosis Drug Imukin

LONDON (Alliance News) - Clinigen Group PLC said Wednesday that it acquired the global rights to osteoporosis drug Imukin from Horizon Pharma PLC.The FTSE 250 pharmaceutical company said it

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.